Verastem

VSTM NASDAQ
1.400
+0.130
+10.24%
已收盘, 17:52 06/14 EDT
开盘
1.260
昨收
1.270
最高
1.450
最低
1.250
成交量
276.64万
成交均量(3M)
246.24万
52周最高
10.35
52周最低
1.160
换手率
3.74%
市值
1.03亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Verastem VSTM股票价格,Verastem股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Verastem, Inc., is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. It is also developing a dual inhibitor of PI3K-delta and PI3K-gamma, which has completed Phase 2 study in indolent non-hodgkin lymphoma. In addition, it is developing the focal adhesion kinase inhibitor defactinib, which is being evaluated in three separate clinical collaborations in combination with immunotherapeutic agents for the treatment of various different cancer types, including pancreatic cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and mesothelioma.
展开 >

最近浏览

名称
价格
涨跌幅